1. Repositório PUCRS

Percorrendo por Autor André Poisl Fay

Ir para: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ou digite as primeiras letras:  
Mostrando regs. 8 a 27 de 65   ◄ anterior       próximo ►  
Data de publicaçãoTítuloAutor(es)
2019Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?André Poisl Fay; ANTONARAKIS, EMMANUEL S.
2016Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of EfficacyTEMPLETON, ARNOUD J.; KNOX, JENNIFER J.; LIN, XUN, et al
2015Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled TrialCHOUEIRI, T. K.; FIGUEROA, D. J.; André Poisl Fay, et al
2015Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspectiveStephen Doral Stefani; Vanessa Teich; André Poisl Fay, et al
2015Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspectiveStephen Doral Stefani; Vanessa Teich; André Poisl Fay, et al
2015Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma.CALLEA, MARCELLA; ALBIGES, LAURENCE; Mampta Gupta, et al
2017Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trialsMOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO, et al
2017Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trialsMOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO, et al
2020Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trialVAN DER HEIJDEN, MICHIEL S; GALSKY, MATTHEW D; PETRYLAK, DANIEL P, et al
2015Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinomaALBIGES, LAURENCE; André Poisl Fay; XIE, WANLING, et al
2017ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysisURUN, YUKSEL; LEOW, JEFFREY J.; André Poisl Fay, et al
2020First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysisMONTEIRO, FERNANDO SABINO M.; SOARES, ANDREY; DEBIASI, MÁRCIO, et al
2015HER2 as a target in invasive urothelial carcinomaBELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE, et al
2015HER2 as a target in invasive urothelial carcinomaBELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE, et al
2018Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials DatabaseAndré Poisl Fay; MCKAY, RANA R.; LIN, XUN, et al
2018Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials DatabaseAndré Poisl Fay; MCKAY, RANA R.; LIN, XUN, et al
2022Intercomparison of radiosensitization induced by gold and iron oxide nanoparticles in human glioblastoma cells irradiated by 6 MV photonsGUERRA, DANIELI B.; OLIVEIRA, ELISA M. N.; SONNTAG, AMANDA R., et al
2022IRONMAN: A Novel International Registry of Men With Advanced Prostate CancerMUCCI, LORELEI A.; VINSON, JACOB; GOLD, THERESA, et al
2015Is angiogenesis still an attractive target in metastatic castration-resistant prostate cancer?André Poisl Fay; BELLMUNT, JOAQUIM
2018Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinomaLana Hamieh; CHOUEIRI, T. K.; B ogorek, et al
Mostrando regs. 8 a 27 de 65   ◄ anterior       próximo ►